Laura Risaliti

Laura Risaliti

Auto-generated profile, based on publicly available information

Laura Risaliti

Department of Chemistry, University of Florence

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2017 in Planta Medica
Verified
Journal Article
Closed access
PDF file
ABAnna Rita Bilia
Anna Rita Bilia
VPVieri Piazzini
Vieri Piazzini
CGClizia Guccione
Clizia Guccione
LRLaura Risaliti
Laura Risaliti
MAMartina Asprea
Martina Asprea
Maria Camilla BergonziMaria Camilla Bergonzi
Maria Camilla Bergonzi
Natural products have been used as a major source of drugs for millennia, and about half of the pharmaceuticals in use today are derived from natural products. However, their efficacy can be limited because of their low hydrophilicity and intrinsic dissolution rate(s), or physical/chemical instability. In addition, they can present scarce absorption, poor pharmacokinetics and bioavailability, scarce biodistribution, first-pass metabolism, trivial penetration and accumulation in the organs of the body, or low targeting efficacy. Novel nanoformulations based on drug delivery systems, namely nanoparticles, micelles, and vesicles, offer significant promise in overcoming these limitations. Nowadays, nanomedicine is crucial in developing appropriate therapeutic treatments of essential drugs, specifically antitumor and antiparasistic agents (i.e., Taxol, vincristine, camptothecin, doxorubicin, artemisinin) and other emerging molecules with pleiotropic functions (i.e., resveratrol, curcumin, salvianolic acid B, honokiol). Additionally, the number of nanoformulations developed with flavonoids, in particular rutin, quercetin, silymarin, and green tea catechins, is constantly increasing, and a significant number of publications have appeared in the last decade pertaining to nanoformulations based on extracts and essential oils. Most of these studies report very promising nanoformulations with sustained release and improved bioavailability at much lower doses than conventional preparations, and in many cases, also a better safety profile.

1 June 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
LRLaura Risaliti
Laura Risaliti
AKAspasia Kehagia
Aspasia Kehagia
EDEirini Daoultzi
Eirini Daoultzi
DLDiamanto Lazari
Diamanto Lazari
Maria Camilla BergonziMaria Camilla Bergonzi
Maria Camilla Bergonzi
ABAnna Rita Bilia
Anna Rita Bilia

1 February 2019 in Engineering
Verified
Journal Article
Open access
MCMarta Casamonti
Marta Casamonti
LRLaura Risaliti
Laura Risaliti
Giulia VantiGiulia Vanti
Giulia Vanti
VPVieri Piazzini
Vieri Piazzini
MBMaria Camilla Bergonzi
Maria Camilla Bergonzi
ABAnna Rita Bilia
Anna Rita Bilia

1 September 2018 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
ABAnna Rita Bilia
Anna Rita Bilia
VPVieri Piazzini
Vieri Piazzini
MAMartina Asprea
Martina Asprea
LRLaura Risaliti
Laura Risaliti
Giulia VantiGiulia Vanti
Giulia Vanti
MBMaria Camilla Bergonzi
Maria Camilla Bergonzi
Over the millennia, plants have represented for Humankind the main source of food, but also a vast resource to maintain health, for prophylactic properties or to cure human and animal diseases. Presently, between 65 and 80% of populations in developing countries use medicinal plants as therapeutic remedies for their primary healthcare and in Europe and USA there is an increasing demand of botanical products both on the form of food supplements and herbal medicinal products. Botanicals on the market are mainly based on traditional (infusions or decoctions), conventional (using organic solvents) and innovative (supercritical CO2 or subcritical water) extracts but there is an increasing demand of essential oils for aromatherapy. Conversely, the clinical use of many extracts is limited due to the need of repeated administrations or high doses because of low hydrophilicity and intrinsic dissolution rate(s), or physical/ chemical instability. Other limits are low absorption, poor pharmacokinetics and bioavailability, scarce biodistribution, first pass metabolism, trivial penetration and accumulation in the organs of the body. In the case of essential oils, the high volatility and instability are further limitations. Nowadays, the design and production of appropriate drug delivery systems, in particular nanosized ones (between 50 and 300 nm), have already entered into clinical use and can offer an advanced approach to optimized the therapeutic efficacy of extracts and essential oils. A successful drug carrier system should have optimal drug loading and release properties, a long shelf life, and exert a much higher therapeutic efficacy as well as lower side effects. Polymeric nanoparticles and lipid based-nanocarriers including micelles, vesicles, nanocochleates, micro- and nanoemulsions represent successful examples of extract nanoformulations overcoming these limitations. This review reports on some paradigmatic success stories of extract and EO nanoformulations with remarkable advantages over conventional formulations, which include increase of solubility, stability, permeation and bioavailability, sustained delivery. Paradigmatic examples include formulations of extracts from Vitex agnus-castus, Sylibum marianum, Phyllanthus amarus, Ginkgo biloba, Panax notoginseng, Hypericum perforatum and thyme essential oil.

1 March 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LRLaura Risaliti
Laura Risaliti
VPVieri Piazzini
Vieri Piazzini
MMMaria Giuseppina Di Marzo
Maria Giuseppina Di Marzo
LBLuigi Brunetti
Luigi Brunetti
RCRoberto Cecchi
Roberto Cecchi
Maria Camilla BergonziMaria Camilla Bergonzi
Maria Camilla Bergonzi

20 December 2019 in Planta Medica
Verified
Conference Paper
Closed access
Giulia VantiGiulia Vanti
Giulia Vanti
VDV Dourdouni
V Dourdouni
DLDiamanto Lazari
Diamanto Lazari
CPChristos Panagiotidis
Christos Panagiotidis
SNSg Ntallis
Sg Ntallis
ABAr Bilia
Ar Bilia
Essential oils (EOs) are complex mixtures of strongly active compounds, but very volatile and sensitive to light, oxygen, moisture and temperature. Loading inside nanostructures can be a strategy to stabilize them and use them in therapy [1]. In the present study, Melissa officinalis L. (Lamiaceae) essential oil was loaded inside glycerosomes (GS) at a concentration of 10 µL/mL and was evaluated for its anti-herpetic activity [2]. GS were prepared by the thin layer evaporation method and characterized by Light Scattering techniques, determining average diameter (about 60 nm), polydispersity index (⋍ 0.2) and ζ-potential (⋍ -30 mV). From the morphological observation by transmission electron microscope, GS appeared as small vesicles with several lamellae and a spherical shape. Moreover, the EO encapsulation efficiency inside the GS, in terms of citral and β-caryophyllene, obtained by HPLC-DAD, was ⋍63 % and ⋍76 % respectively and the EO release, by the dialysis bag method, was very low (⋍15% of citral) within 24h. The same instruments and analytical techniques were adopted to monitor the GS long-term stability until 4 months and no relevant changes were observed in the chemical-physical parameters. Successively, GS were tested with an in vitro antiviral assay against the HSV-1/strain vCLIDA61. From these studies, the antiviral activity of loaded-EO was found to be comparable to free-EO, for high concentrations of EO. Hence, at present, GS seems to be a promising tool in order to administer the EO and replace the conventional anti-herpetic drugs, when drug-resistance forms take place.